NURS 6521 Final Exam 2025/2026 V3 Winter Quarter
Walden University | Advanced Pharmacology – Complete
Exam with Accurate Questions & Answers
Comprehensive Examination
This updated 2025/2026 NURS 6521 Advanced Pharmacology Final Exam
(Version 3 – Winter Quarter, Walden University) resource contains 100 fully
verified questions with correct answers, designed to reflect the exam's focus on
advanced pharmacology. Content covers pharmacokinetics and pharmacodynamics
(20%, 20 questions), major drug classes and therapeutic uses (25%, 25 questions),
adverse effects and drug interactions (20%, 20 questions), prescriptive authority
and evidence-based prescribing (20%, 20 questions), and patient safety and
education (15%, 15 questions). All answers are graded A+ and include rationales
to reinforce clinical judgment, safe prescribing practices, and exam readiness.
Domain 1: Pharmacokinetics and Pharmacodynamics
(Questions 1–20)
Question 1
What is the primary site of drug metabolism in the body?
A. Kidneys
B. Liver
C. Lungs
D. Stomach
Correct Answer: B
Rationale: The liver is the primary organ for drug metabolism, primarily via the
cytochrome P450 enzyme system, which transforms drugs into metabolites for
excretion.
,Question 2
What does the term 'half-life' of a drug refer to?
A. Time to reach peak concentration
B. Time for drug concentration to reduce by half
C. Time for complete drug elimination
D. Time for drug absorption
Correct Answer: B
Rationale: Half-life is the time required for the plasma concentration of a drug to
decrease by 50%, influencing dosing frequency and time to steady-state.
Question 3
Which factor most affects drug bioavailability?
A. First-pass metabolism
B. Drug half-life
C. Plasma protein binding
D. Renal excretion
Correct Answer: A
Rationale: First-pass metabolism in the liver reduces the amount of active drug
reaching systemic circulation, affecting bioavailability. Drugs with high first-pass
metabolism require higher oral doses or alternative routes.
Question 4
What is the primary mechanism of action of beta-blockers?
A. Inhibit ACE
B. Block beta-adrenergic receptors
C. Block calcium channels
D. Inhibit sodium reabsorption
Correct Answer: B
Rationale: Beta-blockers reduce heart rate and contractility by blocking beta-
adrenergic receptors, decreasing sympathetic activity and myocardial oxygen
demand.
,Question 5
What does the term 'therapeutic index' describe?
A. Drug potency
B. Ratio of toxic dose to effective dose
C. Drug absorption rate
D. Drug metabolism rate
Correct Answer: B
Rationale: The therapeutic index (TD50/ED50) measures a drug's safety margin,
with a higher index indicating safer drugs. A narrow therapeutic index requires
careful monitoring.
Question 6
Which route of administration bypasses first-pass metabolism?
A. Oral
B. Intravenous
C. Rectal
D. Sublingual
Correct Answer: B
Rationale: Intravenous administration delivers drugs directly into the bloodstream,
completely avoiding first-pass hepatic metabolism, resulting in 100%
bioavailability.
Question 7
What is the primary effect of a competitive antagonist?
A. Enhances receptor activity
B. Blocks receptor binding
C. Increases drug metabolism
D. Prolongs drug half-life
Correct Answer: B
Rationale: Competitive antagonists bind reversibly to receptors, preventing
agonists from exerting their effects. The blockade can be overcome by increasing
agonist concentration.
, Question 8
Which organ is primarily responsible for drug excretion?
A. Liver
B. Kidneys
C. Lungs
D. Skin
Correct Answer: B
Rationale: The kidneys filter and excrete most drugs and their metabolites via
urine. Renal impairment significantly affects drug clearance and requires dose
adjustment.
Question 9
What is the effect of cytochrome P450 enzyme induction?
A. Slows drug metabolism
B. Increases drug metabolism
C. Reduces drug absorption
D. Prolongs drug action
Correct Answer: B
Rationale: Enzyme induction increases CYP450 activity, accelerating drug
metabolism and reducing drug effects. Inducers like rifampin and phenytoin
decrease concentrations of co-administered drugs.
Question 10
What is the primary action of an agonist?
A. Blocks receptor activity
B. Mimics endogenous ligand
C. Inhibits drug metabolism
D. Reduces drug absorption
Correct Answer: B
Rationale: Agonists bind to receptors and mimic the effects of natural ligands,
activating the receptor and producing a physiologic response.
Walden University | Advanced Pharmacology – Complete
Exam with Accurate Questions & Answers
Comprehensive Examination
This updated 2025/2026 NURS 6521 Advanced Pharmacology Final Exam
(Version 3 – Winter Quarter, Walden University) resource contains 100 fully
verified questions with correct answers, designed to reflect the exam's focus on
advanced pharmacology. Content covers pharmacokinetics and pharmacodynamics
(20%, 20 questions), major drug classes and therapeutic uses (25%, 25 questions),
adverse effects and drug interactions (20%, 20 questions), prescriptive authority
and evidence-based prescribing (20%, 20 questions), and patient safety and
education (15%, 15 questions). All answers are graded A+ and include rationales
to reinforce clinical judgment, safe prescribing practices, and exam readiness.
Domain 1: Pharmacokinetics and Pharmacodynamics
(Questions 1–20)
Question 1
What is the primary site of drug metabolism in the body?
A. Kidneys
B. Liver
C. Lungs
D. Stomach
Correct Answer: B
Rationale: The liver is the primary organ for drug metabolism, primarily via the
cytochrome P450 enzyme system, which transforms drugs into metabolites for
excretion.
,Question 2
What does the term 'half-life' of a drug refer to?
A. Time to reach peak concentration
B. Time for drug concentration to reduce by half
C. Time for complete drug elimination
D. Time for drug absorption
Correct Answer: B
Rationale: Half-life is the time required for the plasma concentration of a drug to
decrease by 50%, influencing dosing frequency and time to steady-state.
Question 3
Which factor most affects drug bioavailability?
A. First-pass metabolism
B. Drug half-life
C. Plasma protein binding
D. Renal excretion
Correct Answer: A
Rationale: First-pass metabolism in the liver reduces the amount of active drug
reaching systemic circulation, affecting bioavailability. Drugs with high first-pass
metabolism require higher oral doses or alternative routes.
Question 4
What is the primary mechanism of action of beta-blockers?
A. Inhibit ACE
B. Block beta-adrenergic receptors
C. Block calcium channels
D. Inhibit sodium reabsorption
Correct Answer: B
Rationale: Beta-blockers reduce heart rate and contractility by blocking beta-
adrenergic receptors, decreasing sympathetic activity and myocardial oxygen
demand.
,Question 5
What does the term 'therapeutic index' describe?
A. Drug potency
B. Ratio of toxic dose to effective dose
C. Drug absorption rate
D. Drug metabolism rate
Correct Answer: B
Rationale: The therapeutic index (TD50/ED50) measures a drug's safety margin,
with a higher index indicating safer drugs. A narrow therapeutic index requires
careful monitoring.
Question 6
Which route of administration bypasses first-pass metabolism?
A. Oral
B. Intravenous
C. Rectal
D. Sublingual
Correct Answer: B
Rationale: Intravenous administration delivers drugs directly into the bloodstream,
completely avoiding first-pass hepatic metabolism, resulting in 100%
bioavailability.
Question 7
What is the primary effect of a competitive antagonist?
A. Enhances receptor activity
B. Blocks receptor binding
C. Increases drug metabolism
D. Prolongs drug half-life
Correct Answer: B
Rationale: Competitive antagonists bind reversibly to receptors, preventing
agonists from exerting their effects. The blockade can be overcome by increasing
agonist concentration.
, Question 8
Which organ is primarily responsible for drug excretion?
A. Liver
B. Kidneys
C. Lungs
D. Skin
Correct Answer: B
Rationale: The kidneys filter and excrete most drugs and their metabolites via
urine. Renal impairment significantly affects drug clearance and requires dose
adjustment.
Question 9
What is the effect of cytochrome P450 enzyme induction?
A. Slows drug metabolism
B. Increases drug metabolism
C. Reduces drug absorption
D. Prolongs drug action
Correct Answer: B
Rationale: Enzyme induction increases CYP450 activity, accelerating drug
metabolism and reducing drug effects. Inducers like rifampin and phenytoin
decrease concentrations of co-administered drugs.
Question 10
What is the primary action of an agonist?
A. Blocks receptor activity
B. Mimics endogenous ligand
C. Inhibits drug metabolism
D. Reduces drug absorption
Correct Answer: B
Rationale: Agonists bind to receptors and mimic the effects of natural ligands,
activating the receptor and producing a physiologic response.
